Loading clinical trials...
Loading clinical trials...
Prognostic Factors for Survival of Patients With Salivary Gland Malignancies
Salivary gland malignancies is very heterogenous group of tumors regarding tumor histology and localization. The aim of this study is to assess main clinical and pathological parameters related to patients survival
The retrospective study enrolled medical charts of the patients treated due to salivaly gland cancers in the Clinic for maxillofacial surgery at Clinical center of Vojvodina in the period of 1. January 1996. to 31. December 2021. Patients demographics, type of the tumor, localization, TNM status and patohystological parameters were evaluated for patients survival and disease free periods
Age
All ages
Sex
ALL
Healthy Volunteers
No
Clinic for maxillofacial surgery Clinical center of Vojvodina
Novi Sad, Serbia
Start Date
January 1, 2022
Primary Completion Date
March 30, 2022
Completion Date
April 30, 2022
Last Updated
May 25, 2022
250
ACTUAL participants
Surgical intervention with or without postoperative adjuvant therapy
PROCEDURE
Lead Sponsor
Clinical Center of Vojvodina
NCT04704661
NCT05884320
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions